Busan 1506 vs MEA Triazine 78% — H2S Scavenger Comparison

Busan 1506 — Product Overview

Busan 1506 is Buckman Laboratories' higher-concentration triazine H2S scavenger, positioned for applications requiring stronger treatment capacity. Like its companion product Busan 1060, the active ingredient is hexahydro-1,3,5-tris(2-hydroxyethyl)-s-triazine. The product is available through Buckman's authorized distribution channel with integrated technical support. Busan 1506 targets oilfield gas sweetening, pipeline treatment, and industrial hydrogen sulfide removal applications across the United States.

• Same CAS 4719-04-4 active ingredient in both products
• Identical scavenging efficiency: 3.1–4.5 gal/lb H2S
• 25–40% lower cost with direct-manufacturer sourcing
• No performance difference in parallel field trials
• Full quality and compliance documentation included

MEA Triazine 78% — Specification Comparison

MEA Triazine 78% from Vasudev Chemo Pharma delivers a guaranteed ≥78% active triazine concentration — the highest commonly available in the market. The product specification includes specific gravity of 1.13–1.15, pH 8.0–10.0, and clear to slightly hazy appearance. Every batch undergoes quality testing with results documented on an independent Certificate of Analysis. Manufacturing under ISO 9001:2015 ensures consistent batch-to-batch quality. The product carries TSCA inventory listing status for US import and ships with full GHS-compliant Safety Data Sheet documentation.

Performance Equivalence in Field Applications

The H2S scavenging performance of Busan 1506 and MEA Triazine 78% is functionally identical because both products rely on the same triazine-H2S reaction pathway. The stoichiometric consumption remains approximately 3.1–4.5 gallons per pound of H2S removed across typical oilfield injection scenarios. Both products perform effectively in direct-pipeline injection, contactor tower applications, and batch treatment operations. Temperature effects, CO2 interference (minimal for both), and by-product characteristics are equivalent. Operators who have run parallel field trials consistently report that treatment outcomes are indistinguishable between branded and generic triazine products when active concentration is equivalent.

Total Cost of Ownership Analysis

Busan 1506 pricing includes Buckman's brand value, distribution infrastructure costs, and technical service components. MEA Triazine 78% from Vasudev Chemo Pharma is priced based on manufacturing cost plus a transparent margin — no distribution layers, no service bundles, no brand premiums. The delivered-cost differential is typically 25–40% in favor of the generic product. For operations consuming 1,000+ gallons per week, annual savings of $50,000–$150,000 are achievable without any reduction in H2S treatment effectiveness. These savings come with equivalent quality documentation and regulatory compliance records.